中国の眼科市場（2020年）：2019年から2025年の地域分析

当レポートは、中国眼科市場について調査しており、セグメント別市場の5年間予測、白内障治療の機会分析、新しいポリシーと規制の議論、私立眼科病院チェーンのプロファイル、中国企業による新規買収、詳細なドライアイ治療予測、商品化された製品とパイプライン製品を含む治療アプローチなどの情報を提供しています。

掲載内容

• 人口統計、経済、医療インフラの分析を含む中国市場の概要
• 疾患有病率データ
• 眼科医、外科医、検眼医、病院、クリニック
• 外科的治療
• 使用されている手術器具と技術
• 眼科用薬物療法レジメン
• 市場実績：5年間の予測
• 28社の企業プロファイル

The new "2020 China Ophthalmic Market Report" features updated forecasts that reflect the effect of COVID-19 on the ophthalmic market. The report also includes updated cataract treatment opportunity analysis, discussion of new policies and regulations, profiles of 10 non-public eye hospital chains, and evaluation of new acquisitions by Chinese companies. In addition, the report features more detailed dry eye treatment forecasts, fueled by a new dry eye disease model.

The "2020 China Ophthalmic Market Report" is the leading industry source for accurate and relevant information on all aspects of the Chinese ophthalmic market. Our report includes a comprehensive overview of the Chinese population and economic conditions. The report covers prevalence of and forecasts for eye diseases and conditions and discusses therapeutic approaches, including commercialized and pipeline products.

The report looks at the market's evolution and forecasts growth over the next five years for 10 segments: cataract, refractive, glaucoma, retina, dry eye, other ophthalmic drugs, diagnostic equipment, multipurpose ophthalmic lasers (exclusive of femtosecond and excimer), single-use surgical devices, and surgical instruments. Each segment includes an analysis of competitors, estimated installed base, and a five-year forecast of market performance.

The following information is also included:

• Overview of China, including an analysis of population demographics, the economy, and health care infrastructure.

• Disease prevalence data.

• Ophthalmologists, surgeons, optometrists, hospitals, and clinics.

• Surgical treatments.

• Surgical instrument and technology usage.

• Ophthalmic pharmaceutical treatment regimens.

• Five-year forecasts for market performance.

• 28 company profiles.

Market Scope has prepared this report for individuals and companies participating in China's ophthalmic market: ophthalmologists, surgeons, hospitals, clinics, manufacturers, distributors, market analysts, industry investors, and anyone else with an interest in the business of ophthalmology in China. The author of this report, Peter Downs, continues to spend significant time in China to better understand the complexities and challenges of this rapidly changing market. This presence greatly impacts the quality of our reporting.

Our Process

Market Scope's industry reports are meticulously prepared by a dedicated team of in-house analysts with over 100 years of collective ophthalmic market research experience. Each data point is driven by a combination of sources, including the following:

• Our proprietary global disease population and demographic models;

• Analysis of company-published financial reports;

• Focused coverage of ophthalmic scientific research, business news, and other activities;

• Attendance and participation in worldwide ophthalmic meetings;

• Interviews and relationships with company executives and practicing physicians.